Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric monoclonal antibody, Human IgG1 (AM122) (Trehalose free)
Product Sizes
100 ug
£995.00
S1N-M12A1-100UG
1 mg
£3515.00
S1N-M12A1-1MG
10 mg
£27195.00
S1N-M12A1-10MG
100 mg
£266569.00
S1N-M12A1-100MG
About this Product
- SKU:
- S1N-M12A1
- Buffer:
- PBS (pH 7.4)
- translate.label.attr.clone:
- AM122
- Clonality:
- Monoclonal
- Extra Details:
- Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM122) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with human IgG1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARS-CoV-2 Spike S1 protein. As verified in competitive ELISA-based and pseudovirus-based neutralization assay, this chimeric monoclonal can potently neutralize all SARS-CoV-2 Variants of Concern (VOCs), including Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1) and Delta (B.1.617.2) .
- Immunogen:
- Spike RBD
- Physical State:
- Liquid
- Purification:
- 0.95
- Reactivities:
- Mouse
- Shipping Conditions:
- Dry Ice
- Storage Conditions:
- -70[o]C
- Supplier:
- ACRO Biosystems
- Type:
- Antibody: Monoclonal Antibody
